Identification of a copper metabolism‐related gene signature for predicting prognosis and immune response in glioma
Open Access
- 1 March 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (8) , 10123-10137
Abstract
Background: Gliomas are highly refractory intracranial cancers characterized by genetic and transcriptional heterogeneity. However, therapeutic options are limited. In the last years, copper‐induced cell death is becoming a prospective treatment strategy for gliomas and other solid tumors, but copper metabolism‐related genes associated with cancer development remain unclear.Methods: We first collected gene expression data from The Cancer Genome Atlas (TCGA) to identify significantly differentially expressed copper metabolism‐related genes in gliomas. Using these genes, we performed COX regression and Least Absolute Shrinkage and Selection Operator (LASSO) regression to construct the prognostic model. The prognostic value of the model was further validated by CGGA testing set. Subsequently, functional analyses were carried out, including gene set enrichment analysis (GSEA), immune infiltration analysis, and mutation analysis. Finally, the expression levels of these genes were verified by immunohistochemical analysis.Results: The prognostic model consisted of 7 genes: CDK1, LOXL2, LOXL3, NFE2L2, SLC31A1, SUMF1 and FDX1. According to this prognosis model, glioma patients could be split into the high‐risk group or low‐risk group, and the low‐risk group showed significantly better prognostic survival (p < 0.001). Moreover, the high‐risk group had higher levels of immune cell infiltration, immune checkpoint genes expression, and higher tumor mutational burden (TMB), which indicates that they might benefit more from immunotherapy. Finally, we confirmed the expression level of FDX1, SUMF1, and SLC31A1 protein as significantly different in glioblastoma, lower‐grade glioma, and non‐tumor brain tissues by immunohistochemical analysis, and the high expression of FDX1 and SLC31A1 protein was related to poor survival in glioma patients.Conclusions: Our study could contribute to the prognosis prediction and decision‐making in patients with gliomas.Keywords
Funding Information
- National Basic Research Program of China (2020YFB0204803)
- Natural Science Foundation of Guangzhou Municipality (2021A1515010256)
This publication has 65 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Genetic alterations and signaling pathways in the evolution of gliomasCancer Science, 2009
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatmentCancer Treatment Reviews, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaNeuro-Oncology, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Undetectable Intracellular Free Copper: The Requirement of a Copper Chaperone for Superoxide DismutaseScience, 1999
- Copper and Zinc levels in normal and malignant tissuesCancer, 1983